(IN BRIEF) Aviva’s recent research, conducted during Ovarian Cancer Awareness Month, reveals significant gaps in the knowledge of ovarian cancer symptoms among UK women. The study found that 62% of women overall, and 73% of those over 55, feel … Read the full press release
Posted in Healthcare, Insurance, Society, United Kingdom
Tagged 400 cases by 2040, 500 new cases, 53% increase, 62% lack knowledge, 7, 73% over 55, 9, 91% claims over 40, age, Aviva, Aviva UK Health, awareness, bloating, BRCA1, BRCA2, delayed GP consultation, Diabetes, diagnostic tests, Dr Suba M, genetic mutations, irritable bowel syndrome, ovarian cancer, pelvic examination, smear test misconception, stomach bug, swollen abdomen, symptoms, UK women, £6.4 million claims
Lynparza is the first PARP inhibitor approved in Japan Lynparza tablets approved as maintenance treatment for women with platinum-sensitive relapsed ovarian cancer regardless of BRCA mutation status CAMBRIDGE, 22-Jan-2018 — /EuropaWire/ — AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged AstraZeneca, Dave Fredrickson, inhibitor, Japan, Lynparza, Lynparza (olaparib), ovarian cancer, PARP, Roy Baynes
First Phase III trial evaluating the addition of an immune checkpoint inhibitor to standard of care in first-line ovarian cancer New investigational regimen will evaluate avelumab in extending progression-free survival in treatment-naïve women Darmstadt, Germany and New York, US, 07-Jul-2016 … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech, Science
Tagged Merck, ovarian cancer, Pfizer, Phase III study JAVELIN Ovarian 100
First new treatment option for women in Europe in more than 15 years for most difficult to treat form of ovarian cancer BASEL, 13-8-2014 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EU) approved the … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?